Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The 138 analyzable patients were all proven mismatch repair mutation carriers for LS (MLH1 = 33%, MSH2 = 47%, MSH6 = 15%, PMS2 = 4%, and EPCAM = 1%).
|
31498154 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Moreover, the mutations in the EpCAM gene lead to congenital tufting enteropathy, severe intestinal epithelium homeostasis disorders, and Lynch and Lynch syndrome.
|
30628064 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Being located immediately upstream of the MSH2 gene, EPCAM abnormalities can affect MSH2 and cause Lynch syndrome.
|
31273487 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype.
|
30916491 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We found a novel large EPCAM-MSH2 duplication associated with LS and the presence of LOHs in regions containing numerous tumor suppressors, raising the hypothesis that these alterations could contribute to cancer susceptibility.
|
31655866 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Among confirmed LS, path_MLH1 variants were most commonly identified in Peru (82%), Mexico (80%), Chile (60%), and path_MSH2/EPCAM variants were most frequently identified in Colombia (80%) and Argentina (47%).
|
30303536 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Genetic counseling and germline analysis for mutations in genes associated with Lynch syndrome (MLH1, MSH2, MSH6, PMS2, and EPCAM) were offered to individuals with PREMM<sub>1,2,6</sub> scores of 5% or higher.
|
28668538 |
2018 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The genetic basis for hereditary nonpolyposis colorectal cancer is the detection of mutations in the MLH1, MSH2, MSH6, PMS2, and EPCAM genes.
|
29776633 |
2018 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Out of the 11 patients, 9 (0.7%) were finally diagnosed as having Lynch syndrome; the responsible genes included MLH1 (n = 1), MSH2 (n = 4), EPCAM (n = 1) and MSH6 (n = 3).
|
27920101 |
2017 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Cytoplasmic MSH2 immunoreactivity in a patient with Lynch syndrome with an EPCAM-MSH2 fusion.
|
27896849 |
2017 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Next to mutations c. 2041G>A in MLH1 gene and c.942+3A>T in MSH2, the deletion mutation encompassing EPCAM is one of the most common causative changes responsible for LS in Poland.
|
28369810 |
2017 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
Biomarker
|
disease |
BEFREE |
We developed a new prediction model, PREMM<sub>5</sub>, that incorporates the genes PMS2 and EPCAM to provide comprehensive LS risk assessment.
|
28489507 |
2017 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The ultimate diagnosis of Lynch syndrome requires documentation of mutation within one of the four MMR genes (MLH1, PMS2, MSH2 and MSH6) or EPCAM, currently achieved by comprehensive sequencing analysis of germline DNA.
|
26895074 |
2016 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Germline deletion of the 3' portion of the Epithelial Cell Adhesion Molecule (EPCAM) gene located 5' upstream of MutS Homolog 2 (MSH2) is a novel mechanism for its inactivation in Lynch syndrome.
|
26613680 |
2016 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Lynch syndrome is a hereditary cancer syndrome associated with high risks of colorectal and endometrial cancer that is caused by pathogenic variants in the mismatch repair genes (MLH1, MSH2, MSH6, PMS2, EPCAM).
|
27363726 |
2016 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
EPCAM-CL can be used to screen for EPCAM deletion-induced Lynch syndrome-associated CRC, whereas EPCAM-PL can be used as an indicator of tumor aggressiveness and poor prognosis in CRC.
|
26528695 |
2016 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Using data from the Colon Cancer Family Registry, we compared the proportion of childhood cancers (diagnosed before 18 years of age) in the first-, second-, and third-degree relatives of 781 probands with a pathogenic mutation in one of the MMR genes; MLH1 (n = 275), MSH2 (n = 342), MSH6 (n = 99), or PMS2 (n = 55) or in EPCAM (n = 10) (Lynch syndrome families), with that of 5073 probands with MMR-deficient colorectal cancer (non-Lynch syndrome families).
|
25963852 |
2015 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
Biomarker
|
disease |
CTD_human |
Microsatellite instability: an update.
|
25701956 |
2015 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Larger numbers of Lynch syndrome families and screening of the two additional predisposition genes, PMS2 and EPCAM, are needed in order to decipher the full spectrum of mutations associated with Lynch syndrome predisposition in Cyprus.
|
25133505 |
2014 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The identification of an EPCAM founder mutation has useful implications for the molecular diagnosis of LS in Spain.
|
23530899 |
2014 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Lynch syndrome is the most common inherited CRC syndrome and is associated with mutations in DNA mismatch repair genes, mainly MLH1 and MSH2 but also MSH6, PMS2, and EPCAM.
|
23891921 |
2014 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Our study's aim was to explore EPCAM expression in colorectal carcinomas of MSH2-associated LS cases to evaluate the usefulness of EPCAM protein expression in the algorithm approach to LS population screening.
|
23026194 |
2013 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
|
23801599 |
2013 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
|
23264089 |
2013 |
Hereditary Nonpolyposis Colorectal Cancer
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review.
|
23938213 |
2013 |